Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
Clinical trial NCT04923542 · RECRUITING
Trial details
- NCT number
- NCT04923542
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2026-11-05
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.